industrie – Doliprane doit rester français pour préserver la souveraineté sanitaire

This written question concerns the production of Doliprane, a widely used painkiller, and its potential impact on France's health sovereignty. It raises concerns about ensuring domestic supply and control over essential medicines. The question seeks to understand the government's position on maintaining French production of Doliprane to safeguard national health independence and resilience in the pharmaceutical sector.